Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year.
Burden of disease
Coronavirus
Covid-19
DALY
Disability-adjusted life years
European burden of disease network
Malta
Population health
YLD
YLL
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
09 10 2021
09 10 2021
Historique:
received:
02
07
2021
accepted:
28
09
2021
entrez:
10
10
2021
pubmed:
11
10
2021
medline:
16
10
2021
Statut:
epublish
Résumé
Disability-adjusted life years (DALYs) combine the impact of morbidity and mortality, allowing for comprehensive comparisons of the population. The aim was to estimate the DALYs due to Covid-19 in Malta (March 2020-21) and investigate its impact in relation to other causes of disease at a population level. Mortality and weekly hospital admission data were used to calculate DALYs, based on the European Burden of Disease Network consensus Covid-19 model. Covid-19 infection duration of 14 days was considered. Sensitivity analyses for different morbidity scenarios, including post-acute consequences were presented. An estimated 70,421 people were infected (with and without symptoms) by Covid-19 in Malta (March 2020-1), out of which 1636 required hospitalisation and 331 deaths, contributing to 5478 DALYs. These DALYs positioned Covid-19 as the fourth leading cause of disease in Malta. Mortality contributed to 95% of DALYs, while post-acute consequences contributed to 60% of morbidity. Covid-19 over 1 year has impacted substantially the population health in Malta. Post-acute consequences are the leading morbidity factors that require urgent targeted action to ensure timely multidisciplinary care. It is recommended that DALY estimations in 2021 and beyond are calculated to assess the impact of vaccine roll-out and emergence of new variants.
Sections du résumé
BACKGROUND
Disability-adjusted life years (DALYs) combine the impact of morbidity and mortality, allowing for comprehensive comparisons of the population. The aim was to estimate the DALYs due to Covid-19 in Malta (March 2020-21) and investigate its impact in relation to other causes of disease at a population level.
METHODS
Mortality and weekly hospital admission data were used to calculate DALYs, based on the European Burden of Disease Network consensus Covid-19 model. Covid-19 infection duration of 14 days was considered. Sensitivity analyses for different morbidity scenarios, including post-acute consequences were presented.
RESULTS
An estimated 70,421 people were infected (with and without symptoms) by Covid-19 in Malta (March 2020-1), out of which 1636 required hospitalisation and 331 deaths, contributing to 5478 DALYs. These DALYs positioned Covid-19 as the fourth leading cause of disease in Malta. Mortality contributed to 95% of DALYs, while post-acute consequences contributed to 60% of morbidity.
CONCLUSIONS
Covid-19 over 1 year has impacted substantially the population health in Malta. Post-acute consequences are the leading morbidity factors that require urgent targeted action to ensure timely multidisciplinary care. It is recommended that DALY estimations in 2021 and beyond are calculated to assess the impact of vaccine roll-out and emergence of new variants.
Identifiants
pubmed: 34627228
doi: 10.1186/s12889-021-11893-4
pii: 10.1186/s12889-021-11893-4
pmc: PMC8501913
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1827Informations de copyright
© 2021. The Author(s).
Références
Int J Environ Res Public Health. 2021 Mar 05;18(5):
pubmed: 33807869
Arch Public Health. 2016 Aug 22;74:37
pubmed: 27551405
Int J Equity Health. 2021 Sep 26;20(1):214
pubmed: 34565406
J Community Health. 2021 Jun;46(3):618-625
pubmed: 32936428
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057
pubmed: 32267833
Am J Infect Control. 2021 Jan;49(1):21-29
pubmed: 32659413
Z Gesundh Wiss. 2020 May 30;:1-6
pubmed: 32837836
Popul Health Metr. 2015 Apr 03;13:10
pubmed: 26778920
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
Ann Intern Med. 2021 May;174(5):655-662
pubmed: 33481642
Z Gesundh Wiss. 2021 Feb 21;:1-8
pubmed: 33643778
Arch Public Health. 2020 Jul 23;78:68
pubmed: 32760586
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
PLoS One. 2020 Aug 26;15(8):e0238215
pubmed: 32845926
Int J Public Health. 2020 Jul;65(6):719-720
pubmed: 32691080